Cargando…

FGF401 and vinorelbine synergistically mediate antitumor activity and vascular normalization in FGF19-dependent hepatocellular carcinoma

Hepatocellular carcinoma (HCC) is a lethal cancer with limited therapeutic options, and standard therapy with sorafenib provides only modest survival benefits. Fibroblast growth factor 19 (FGF19) has been proposed as a driver oncogene, and targeting its receptor, FGFR-4, may provide a better alterna...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huynh, Hung, Prawira, Aldo, Le, Thi Bich Uyen, Vu, Thanh Chung, Hao, Huai-Xiang, Huang, Alan, Wang, Youzhen, Porta, Diana Graus
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8080677/ https://www.ncbi.nlm.nih.gov/pubmed/33235319 http://dx.doi.org/10.1038/s12276-020-00524-4

Ejemplares similares

A first-in-human phase 1/2 study of FGF401 and combination of FGF401 with spartalizumab in patients with hepatocellular carcinoma or biomarker-selected solid tumors
por: Chan, Stephen L., et al.
Publicado: (2022)

Bevacizumab Augments the Antitumor Efficacy of Infigratinib in Hepatocellular Carcinoma
por: Le, Thi Bich Uyen, et al.
Publicado: (2020)

Ribociclib enhances infigratinib‐induced cancer cell differentiation and delays resistance in FGFR‐driven hepatocellular carcinoma
por: Prawira, Aldo, et al.
Publicado: (2020)

Vinorelbine Augments Radiotherapy in Hepatocellular Carcinoma
por: Yeoh, Kheng Wei, et al.
Publicado: (2020)

Upregulation of the ErbB family by EZH2 in hepatocellular carcinoma confers resistance to FGFR inhibitor
por: Prawira, Aldo, et al.
Publicado: (2021)

FGF19 subfamily members: FGF19 and FGF21
por: Dolegowska, Katarzyna, et al.
Publicado: (2019)

Infigratinib Mediates Vascular Normalization, Impairs Metastasis, and Improves Chemotherapy in Hepatocellular Carcinoma
por: Huynh, Hung, et al.
Publicado: (2019)

Contribution of machine learning to tumor growth inhibition modeling for hepatocellular carcinoma patients under Roblitinib (FGF401) drug treatment
por: Wilbaux, Mélanie, et al.
Publicado: (2022)

The Fgf8 subfamily (Fgf8, Fgf17 and Fgf18) is required for closure of the embryonic ventral body wall
por: Boylan, Michael, et al.
Publicado: (2020)

TGF beta inhibits HGF, FGF7, and FGF10 expression in normal and IPF lung fibroblasts
por: Correll, Kelly A., et al.
Publicado: (2018)

Fgf22 regulated by Fgf3/Fgf8 signaling is required for zebrafish midbrain development
por: Miyake, Ayumi, et al.
Publicado: (2013)

FGF19 and FGF21: In NASH we trust
por: Talukdar, Saswata, et al.
Publicado: (2020)

Repression of myogenic differentiation by aFGF, bFGF, and K-FGF is dependent on cellular heparan sulfate
Publicado: (1992)

Fundamentals of FGF19 & FGF21 Action In Vitro and In Vivo
por: Adams, Andrew C., et al.
Publicado: (2012)

Multifunctional Nanocomposite Films for Synergistic Delivery of bFGF and BMP-2
por: Qi, Wei, et al.
Publicado: (2017)

FGF19 and FGF21 for the Treatment of NASH—Two Sides of the Same Coin? Differential and Overlapping Effects of FGF19 and FGF21 From Mice to Human
por: Henriksson, Emma, et al.
Publicado: (2020)

The Antitumor Effect of Gekko Sulfated Glycopeptide by Inhibiting bFGF-Induced Lymphangiogenesis
por: Ding, Xiu-Li, et al.
Publicado: (2016)

Analysis of FGF-Dependent and FGF-Independent Pathways in Otic Placode Induction
por: Yang, Lu, et al.
Publicado: (2013)

Expression of FGF8, FGF18, and FGFR4 in Gastroesophageal Adenocarcinomas
por: Jomrich, Gerd, et al.
Publicado: (2019)

The Complexity of FGF23 Effects on Cardiomyocytes in Normal and Uremic Milieu
por: Figurek, Andreja, et al.
Publicado: (2021)

Phosphate and FGF-23
por: Jüppner, Harald
Publicado: (2011)

FGF23 and inflammation
por: Sharaf El Din, Usama A A, et al.
Publicado: (2017)

The FGF metabolic axis
por: Li, Xiaokun
Publicado: (2019)

VEGF, FGF1, FGF2 and EGF gene polymorphisms and psoriatic arthritis
por: Butt, Christopher, et al.
Publicado: (2007)

Nuclear Translocation of fibroblast growth factor (FGF) receptors in response to FGF-2
Publicado: (1996)

The Suitability of FGF21 and FGF23 as New Biomarkers in Endometrial Cancer Patients
por: Cymbaluk-Płoska, Aneta, et al.
Publicado: (2020)

Biological and pharmacological functions of the FGF19- and FGF21-coreceptor beta klotho
por: Aaldijk, Alexandra S., et al.
Publicado: (2023)

A Normal FGF23 Does Not Preclude Tumor‐Induced Osteomalacia
por: Nandam, Neeharika, et al.
Publicado: (2020)

FGF15 promotes neurogenesis and opposes FGF8 function during neocortical development
por: Borello, Ugo, et al.
Publicado: (2008)

FGF1 and FGF19 reverse diabetes by suppression of the hypothalamic–pituitary–adrenal axis
por: Perry, Rachel J., et al.
Publicado: (2015)

Ghrelin Ameliorates Traumatic Brain Injury by Down-Regulating bFGF and FGF-BP
por: Shao, Xuefei, et al.
Publicado: (2018)

Molecular elements in FGF19 and FGF21 defining KLB/FGFR activity and specificity
por: Agrawal, Archita, et al.
Publicado: (2018)

FGF6 and FGF9 regulate UCP1 expression independent of brown adipogenesis
por: Shamsi, Farnaz, et al.
Publicado: (2020)

Association between FGF19, FGF21 and lipocalin-2, and diabetes progression in PCOS
por: Cheng, Feifei, et al.
Publicado: (2021)

Hyperphosphatemia with elevated serum PTH and FGF23, reduced 1,25(OH)(2)D and normal FGF7 concentrations characterize patients with CKD
por: Kritmetapak, Kittrawee, et al.
Publicado: (2021)

Synergistic Antitumor Efficacy Mediated by Liposomal Co-Delivery of Polymeric Micelles of Vinorelbine and Cisplatin in Non-Small Cell Lung Cancer
por: Wang, Shuhang, et al.
Publicado: (2021)

FGF gets in your bones
por: LeBrasseur, Nicole
Publicado: (2005)

FGF-23 in bone biology
por: Wesseling-Perry, Katherine
Publicado: (2009)

Evolution of the FGF Gene Family
por: Oulion, Silvan, et al.
Publicado: (2012)

FGF21 and Cardiac Physiopathology
por: Planavila, Anna, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_qs49kh5qpjdh4oshrmk2n1ju61